A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population

Summary

This is a single center single arm study of 50 patients to 1) determine the safety of tranexamic acid in the chronic subdural hematoma population following surgical drainage of chronic subdural hematomas and 2) determine if the use of oral tranexamic acid reduces the rate of ipsilateral recurrence following drainage of chronic subdural hematomas. This will be compared to historical controls. This study intends to be a prerequisite to a large nationally funded randomized control trial.

Timeline

Start

2015-11-01

Primary completion

2017-08-01

Completion

2018-06-12

Drugs

Indications

No indication recorded.